GentiBio is an emerging biotherapeutics company co-founded by pioneers in Treg biology and synthetic immunology from Seattle Children’s Research Institute, Benayroya Research Institute, and MIGAL Gaililee Research Institute. GentiBio is focused on the development of EngTregs programmed to treat autoimmune, alloimmune, autoinflammatory and allergic diseases. GentiBio’s proprietary autologous and allogeneic EngTregs platform integrates key complimentary technologies needed to successfully restore immune tolerance and overcome major limitations in existing regulatory T-cell therapeutics.
GentiBio is seeking to build an organization with an exceptional company culture focused on empowerment, care for our team members, an appreciation for diversity and inclusion, and the development of our people. As such, we are looking for candidates who are not just great scientists but individuals who are looking to contribute to building and modeling an outstanding company culture – and having fun while doing so.
GentiBio is building corporate operations in both the Boston and Seattle. We are looking for outstanding leaders and scientists to join our team in both of our locations.
GentiBio is seeking a motivated Scientist to join our exciting, fast growing, and well financed team to develop novel cell therapies for autoimmune diseases. This individual will report to the Senior Scientist leading the early development programs, and help the team to engineer and evaluate indication-specific EngTregs in vitro and in vivo. In this position, the candidate will have the opportunity to utilize cutting-edge cellular and molecular techniques to generate the next generation of cell therapies for autoimmune diseases, with high visibility to the senior leadership team.
Qualifications and Education Requirements